SOUTHWEST ONCOLOGY GROUP

西南肿瘤集团

• 批准号: 2092140
• 负责人: FREDERICK J. MEYERS
• 金额: $ 9.69万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-01-01 至 1997-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2092140
• 关键词: acute leukemia; acute myelogenous leukemia; adenoma; adenosine deaminase; aminopterin; antineoplastics; bladder neoplasm; bleomycin; bone marrow transplantation; breast neoplasms; cancer prevention; carcinogens; chemoprevention; cis platinum compound; clinical trials; colorectal neoplasms; combination cancer therapy; combination chemotherapy; cooperative study; disease /disorder model; drug interactions; drug resistance; endocrine neoplasm; enzyme inhibitors; esophagus neoplasm; etoposide; flow cytometry; genetically modified animals; hairy cell leukemia; health education; human subject; human therapy evaluation; interferon alpha; laboratory mouse; liver neoplasms; lung neoplasms; lymphoma; melanoma; metastasis; mitomycin C; monoclonal antibody; mycosis fungoides lymphoma; neoplasm /cancer chemotherapy; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer relapse /recurrence; neoplasm /cancer surgery; nutrition related tag; polymerase chain reaction; prostate neoplasms; retinoate; small cell lung cancer; somatostatin; stomach neoplasms; stomatitis; tamoxifen; testis neoplasms

The University of California, Davis Cancer Clinical Trials Program is a dynamic and diverse group of university and private practice physicians and nurses who are very successful at NCI-sponsored cooperative group clinical trials. The Clinical Trials Program is housed in our 55,000 square foot cancer treatment center. Multidisciplinary clinics provide to patients a balance of opinions and support for entry into protocol therapy. The success of our outreach program in the first four years of SWOG membership is presented as a continuation of the CGOP program and a transference of four competent and established CGOP sites into a formal consortium agreement. The consortia members include the largest prepaid HMO in the U.S.A., the largest military hospital on the West Coast, the only clinical trials organization in Northern Nevada, and a 6-member private practice group with impressive credentials. The broadest objective of this proposal is to provide protocol governed therapy to the Central California population. However, we have aims specific to U.C. Davis. 1) To enhance the understanding of the biology of cancer in patients enrolled in SWOG protocols, specifically in urologic oncology and hematologic oncology using flow cytometry, molecular biology and cytogenetics. 2) To provide clinical science sophistication in urologic oncology, lung cancer, and hematologic oncology. 3) To improve the access of protocol-governed therapy to underserved minority patients in our area. 4) To increase cancer control activities, especially in ethnic minority patients. We will accomplish these goals within a sophisticated and integrated management team that includes a balance of enthusiasm and rigid quality control activities.

加州大学戴维斯分校癌症临床试验项目是 充满活力且多元化的大学和私人执业医生群体 以及在 NCI 赞助的合作小组中非常成功的护士 临床试验。 临床试验项目位于我们的 55,000 平方英尺癌症治疗中心。 多学科诊所提供 向患者提供意见平衡并支持加入方案 治疗。 我们的外展计划在前四年取得了成功 SWOG 会员资格是 CGOP 计划的延续，也是 将四个有能力且已建立的 CGOP 站点转变为正式的 联合体协议。 财团成员包括最大的预付费 美国HMO，西海岸最大的军事医院， 内华达州北部唯一的临床试验组织，有 6 名成员 拥有令人印象深刻的资历的私人执业团队。 最广泛的 该提案的目的是向患者提供方案管理的治疗 加利福尼亚州中部人口。 然而，我们有专门针对加州大学的目标。 戴维斯. 1) 增强患者对癌症生物学的了解 参加了 SWOG 协议，特别是泌尿肿瘤学和 使用流式细胞术、分子生物学和 细胞遗传学。 2) 提供泌尿肿瘤学、肺肿瘤学的临床科学复杂性 癌症和血液肿瘤学。 3) 改善服务不足的人群获得方案管理治疗的机会 我们地区的少数民族患者。 4) 加强癌症控制活动，特别是少数民族的癌症控制活动 患者。 我们将在复杂且综合的框架内实现这些目标 热情与严格素质相平衡的管理团队 控制活动。